ES553467A0 - Un procedimiento para preparar derivados de dihidropiridazina - Google Patents

Un procedimiento para preparar derivados de dihidropiridazina

Info

Publication number
ES553467A0
ES553467A0 ES553467A ES553467A ES553467A0 ES 553467 A0 ES553467 A0 ES 553467A0 ES 553467 A ES553467 A ES 553467A ES 553467 A ES553467 A ES 553467A ES 553467 A0 ES553467 A0 ES 553467A0
Authority
ES
Spain
Prior art keywords
dihydropyridazine
procedure
preparing derivatives
derivatives
preparing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES553467A
Other languages
English (en)
Other versions
ES8706644A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Smith Kline and French Laboratories Ltd
Original Assignee
Smith Kline and French Laboratories Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858507941A external-priority patent/GB8507941D0/en
Priority claimed from GB858509605A external-priority patent/GB8509605D0/en
Application filed by Smith Kline and French Laboratories Ltd filed Critical Smith Kline and French Laboratories Ltd
Publication of ES8706644A1 publication Critical patent/ES8706644A1/es
Publication of ES553467A0 publication Critical patent/ES553467A0/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
ES553467A 1985-03-27 1986-03-26 Un procedimiento para preparar derivados de dihidropiridazina Expired ES8706644A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858507941A GB8507941D0 (en) 1985-03-27 1985-03-27 Chemical compounds
GB858509605A GB8509605D0 (en) 1985-04-15 1985-04-15 Chemical compounds

Publications (2)

Publication Number Publication Date
ES8706644A1 ES8706644A1 (es) 1987-06-16
ES553467A0 true ES553467A0 (es) 1987-06-16

Family

ID=26289046

Family Applications (1)

Application Number Title Priority Date Filing Date
ES553467A Expired ES8706644A1 (es) 1985-03-27 1986-03-26 Un procedimiento para preparar derivados de dihidropiridazina

Country Status (9)

Country Link
US (1) US4766122A (es)
EP (1) EP0199465B1 (es)
AU (1) AU581066B2 (es)
CA (1) CA1251448A (es)
DE (1) DE3679100D1 (es)
DK (1) DK135886A (es)
ES (1) ES8706644A1 (es)
GR (1) GR860799B (es)
PT (1) PT82261B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU581324B2 (en) * 1985-07-05 1989-02-16 Smith Kline & French Laboratories Limited Substituted 6-phenyl-4,5-dihydro pyradazin-3-ones
GB8603780D0 (en) * 1986-02-15 1986-03-19 Smith Kline French Lab Chemical compounds
JPH0629254B2 (ja) * 1986-09-08 1994-04-20 帝国臓器製薬株式会社 ピリダジノン誘導体
US4970210A (en) * 1987-07-17 1990-11-13 Abbott Laboratories Triazinone lipoxygenase compounds
DE3735207A1 (de) * 1987-10-17 1989-04-27 Basf Ag Mittel auf der basis von phenylpyridazinon-derivaten zur wachstumsfoerderung und fettreduktion bei tieren
US9849132B2 (en) 2014-01-08 2017-12-26 Intra-Cellular Therapies, Inc. Products and pharmaceutical compositions
CN107205999B (zh) 2014-12-06 2021-08-03 细胞内治疗公司 有机化合物
US10105349B2 (en) 2014-12-06 2018-10-23 Intra-Cellular Therapies, Inc. Organic compounds

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1670043C3 (de) * 1966-01-07 1975-05-22 Basf Ag, 6700 Ludwigshafen Verfahren zur Herstellung von 3-(Aminophenyl)-pyridazon-(6)-derivaten
US3746712A (en) * 1971-06-08 1973-07-17 A Ross 6-(substituted-phenyl)-5-methyl-4,5-dihydro-3(2h)-pyridazinones
US4397854A (en) * 1981-05-14 1983-08-09 Warner-Lambert Company Substituted 6-phenyl-3(2H)-pyridazinones useful as cardiotonic agents
JPS58113180A (ja) * 1981-12-28 1983-07-05 Mitsui Toatsu Chem Inc ピリダジノン誘導体
US4503061A (en) * 1983-07-22 1985-03-05 Warner-Lambert Company Substituted phenyl-pyridinones as cardiotonic agents
US4602019A (en) * 1983-04-22 1986-07-22 Warner-Lambert Company Indeno[1,2-c]pyridazin-3-one derivatives useful as cardiotonic and antihypertensive agents
HU193067B (en) * 1983-12-14 1987-08-28 Mitsubishi Chem Ind Process for the production of new pyridazinon-derivatives and of their salts
GB8400863D0 (en) * 1984-01-13 1984-02-15 Smith Kline French Lab Chemical compounds
GB8603780D0 (en) * 1986-02-15 1986-03-19 Smith Kline French Lab Chemical compounds

Also Published As

Publication number Publication date
US4766122A (en) 1988-08-23
DE3679100D1 (de) 1991-06-13
CA1251448A (en) 1989-03-21
EP0199465A3 (en) 1987-09-02
EP0199465B1 (en) 1991-05-08
DK135886A (da) 1986-09-28
ES8706644A1 (es) 1987-06-16
DK135886D0 (da) 1986-03-24
PT82261A (en) 1986-04-01
GR860799B (en) 1986-07-21
PT82261B (en) 1988-01-07
AU5504286A (en) 1986-10-16
EP0199465A2 (en) 1986-10-29
AU581066B2 (en) 1989-02-09

Similar Documents

Publication Publication Date Title
ES554380A0 (es) Un procedimiento para preparar derivados de 8-fenilxantina
ES554567A0 (es) Un procedimiento para preparar derivados de 8-amino-purina
ES557215A0 (es) Un procedimiento para la preparacion de derivados de androstendiona 4-sustituida
ES555646A0 (es) Un procedimiento para producir derivados de 4-0-sulfonil-uracilo
ES556026A0 (es) Un procedimiento para preparar derivados de tienopiridona
ES546482A0 (es) Un procedimiento para la preparacion de derivados monoamidi-cos de etilendiamina
ES550819A0 (es) Un procedimiento para preparar nuevos derivados de cefem.
ES557522A0 (es) Procedimiento para preparar derivados de cinolina
ES554286A0 (es) Un procedimiento para la preparacion de nuevos derivados glicopepticos
ES557691A0 (es) Procedimiento para preparar derivados de imidazolilalquilguanidina
ES557396A0 (es) Un procedimiento para preparar derivados arilicos de dienamidas
ES553952A0 (es) Un procedimiento para preparar derivados sinteticos de pseudopterosina
ES552617A0 (es) Un procedimiento para preparar derivados de bencimidazol
ES554238A0 (es) Un precedimiento para preparar derivados de ciclopentil-eter
ES552955A0 (es) Procedimiento para preparar derivados de bencimidazol substituidos
ES544970A0 (es) Un procedimiento para la preparacion de derivados de benzo- tiofeno
ES552910A0 (es) Un procedimiento para preparar derivados de indol
ES553467A0 (es) Un procedimiento para preparar derivados de dihidropiridazina
ES557370A0 (es) Procedimiento para preparar derivados de (dihidro-4,5-1h-imidazolil-2)-dihidro-2,3-indol
ES557566A0 (es) Un procedimiento para preparar derivados de azirino-pirrolo-indol-diona
ES553814A0 (es) Un procedimiento para preparar nuevos derivados de aminocetona
ES554371A0 (es) Procedimiento para preparar derivados de benzisoselenazolilo
ES546574A0 (es) Procedimiento para preparar derivados de saframicina a
ES551252A0 (es) Un procedimiento para preparar derivados de 4 4-dialquil- -2-azetidinomas
ES554469A0 (es) Un procedimiento para la preparacion de derivados de mitomicina c